Vienna - Delayed Quote EUR

EGB OE TS.Z./DUERR (AT0000A31U42.VI)

Compare

1.7100

+0.0200

(+1.18%)

At close: December 20 at 5:25:01 PM GMT+1

The comeback of REITs: Top ways to play commercial real estate

Recent indications from the Federal Reserve of fewer rate cuts next year have served as a reality check for commercial real estate. But the sector may finally regain momentum in 2025.

Yahoo Finance 14 hours ago

EXR

AHR

PLD
Singapore Post Shares Slide After CEO Fired Over Whistleblower Report

(Bloomberg) -- Singapore Post Ltd. shares slumped by the most in more than four years after the firm fired its chief executive officer and a number of other senior executives following allegations related to its international e-commerce logistics parcels business.Most Read from BloombergReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiHo Chi Minh City Opens First Metro Line After Years of DelayNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York

Bloomberg 3 hours ago

SPSTY
Donald Trump’s Agenda Has New Enforcers: Charlie Kirk and a Legion of Influencers

On podcasts, posts and college campuses, conservatives push their worldview and the president-elect’s policies.

The Wall Street Journal 5 hours ago

RUM

RUMBW
Singapore Post fires CEO over handling of whistleblower report

The alleged misconduct reported by the whistleblower related to several employees who worked in the company's international e-commerce logistics parcels business, the company said in a statement, without giving further details. CEO Vincent Phang, the chief of the company's international business unit Li Yu, and Chief Financial Officer Vincent Yik had been dismissed after the company found they had been "negligent" in handling the case and misrepresented it before an audit committee, it added. Chair Simon Israel will oversee senior management of Singapore Post in the interim.

Reuters 11 hours ago

SPSTY
Why Is NIO Inc. (NIO) the Best Small Cap EV Stock to Invest In?

We recently compiled a list of the 11 Small Cap EV Stocks to Invest In. In this article, we are going to take a look at where NIO Inc. (NYSE:NIO) stands against the other small-cap EV stocks. An Overview of the Global Electric Vehicle Market The global electric vehicle (EV) market continues to expand, driven […]

Insider Monkey 14 hours ago

NIO
We're Interested To See How IonQ (NYSE:IONQ) Uses Its Cash Hoard To Grow

We can readily understand why investors are attracted to unprofitable companies. By way of example, IonQ ( NYSE:IONQ...

Simply Wall St. 15 hours ago

IONQ

IONQ-WS
Is Merck the Next Big Weight-Loss Stock?

Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market. Merck on Dec. 16 said it had just inked a license agreement with a Chinese biopharma company called Hansoh Pharma that could presage its merits as a weight-loss stock in the coming years. Per the terms of that deal, Merck will get the exclusive worldwide rights to develop and then sell HS-10535, a preclinical-stage candidate that could potentially be useful for treating a few high-profile cardiometabolic disorders, including obesity and perhaps type 2 diabetes.

Motley Fool 17 hours ago

NVO
The Investing Cult Fueling MicroStrategy’s Ascent: ‘Have Fun Staying Poor’

The rally has been propelled by a group of rabid followers who are mixing songs, pouring whisky and spending hundreds of hours researching the stock.

The Wall Street Journal 18 hours ago

MSTR

PLTR

TSLA
China’s Nio Unveils $108,000 EV to Take on Porsche, Mercedes

(Bloomberg) -- Chinese electric car maker Nio Inc. started sales of its most expensive car as it seeks to double deliveries in 2025 and eventually become profitable. Most Read from BloombergReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiHo Chi Minh City Opens First Metro Line After Years of DelayNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisThe 10-year-old automaker official

Bloomberg 23 hours ago

NIO

LI
Palantir Technologies (PLTR) Extends $400M Partnership with U.S. Army to Enhance Data and AI Capabilities

We recently published a list of 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a look at where Palantir Technologies Inc. (NASDAQ:PLTR) stands against other buzzing AI stocks on latest news and ratings. Predictions of artificial intelligence reaching human-level intelligence have been made for over 50 […]

Insider Monkey yesterday

PLTR
China's Nio introduces Firefly brand to take on BMW's Mini

Nio unveiled a lower-cost brand named Firefly on Saturday that it touted as a rival to Mercedes' Smart and BMW's Mini in the Chinese electric vehicle maker's latest bid to broaden its customer base and boost sales. CEO William Li announced the new brand at an annual company event in Guangzhou and said pre-sales would start immediately with prices starting at 148,800 yuan ($20,394). "We are building the Firefly car to be smarter than Mini and be more Mini than smart cars," Li said.

Reuters yesterday

NIO
Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy?

It's not a secret: The cannabis industry has been a major disappointment since Canada legalized recreational use in 2018. Tilray's CEO, Irwin Simon, recently made a bold prediction along those lines. Is legalization on the way in the U.S.?

Motley Fool yesterday

TLRY
Novo obesity data positive for Eli Lilly and Amgen, says UBS

UBS analyst Trung Huynh says Novo Nordisk’s (NVO) CagriSema Phase 3 topline obesity data “underwhelmed,” a positive read-through to Eli Lilly (LLY) and Amgen (AMGN). CagriSema achieved an average weight loss of 20.4%, below Novo’s prior guidance of 25% and inferior to Lilly’s tirzepatide at a similar timepoint, the analyst tells investors in a research note. UBS views the CagriSema’s obesity readout a positive read-through to Lilly, “validating again tirzepatide’s best-in-class profile.” It also

TipRanks yesterday

NONOF

NVO

AMGN
Jefferies sees Novo dropping ‘at least’ 10%-15% on obesity data

Jefferies analyst Peter Welford says the first headline from Novo Nordisk’s (NVO) Phase III CagriSema obesity data “disappoint” with 20.4% absolute weight loss and patient adherence likely suggesting tolerability concerns. The firm’s buy-side survey suggested most anticipated 25%-27% absolute weight loss with fastrointestinal tolerability to be broadly similar to Wegovy. Jefferies notes its $7.75B peak CagriSema sales are well below the $20B-plus consensus. It expects the Novo shares to be down

TipRanks yesterday

NONOF

NVO
Weight loss seen with Novo’s CagriSema weaker than expected, says BofA

BofA analyst Sachin Jain notes that Novo Nordisk (NVO) shares are down about 25%, which is “what we expected in this data scenario,” as CagriSema weight loss data is not as differentiated compared to Eli Lilly’s (LLY) Zepbound as was expected. Weight loss in the REDEFINE 1 trial at about 20.4% is “essentially in line” with Zepbound at 21%, and not high enough to create a barrier relative to future competition, says the analyst. With that said, the data is still superior to Wegovy and sufficient

TipRanks yesterday

LLY

NONOF

NVO
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Santa Claus will soon be on his way delivering presents to kids around the world. Three Motley Fool contributors think they've identified fantastic stocks that could be in a good position to benefit from a Santa Claus rally. Here's why they chose AbbVie (NYSE: ABBV), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX).

Motley Fool yesterday

VRTX

NVO

ABBV
How to Build a High-Quality Passive Income-Producing Real Estate Portfolio for Less Than $250 at a Time

Investing in real estate can be a fantastic way to generate passive income. Rental properties typically throw off more cash than their monthly expenses, enabling investors to pocket the difference as passive income. There are lots of ways to invest in rental properties.

Motley Fool yesterday

O

EXR

INVH
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Since Eli Lilly reported third-quarter earnings on Oct. 30, its shares have had a prolonged sell-off.

Motley Fool yesterday

LLY

NVO
Nio: Buy, Sell, or Hold?

Nio (NYSE: NIO) is a fast-growing Chinese electric vehicle (EV) manufacturer looking to capitalize on a rapidly expanding market opportunity with its focus on high-performance electric SUVs and sedans. According to a report published by Frost & Sullivan, China's electric vehicle (EV) market is expected to grow by 16% compounded annually through 2030. Founded in 2014 and headquartered in Shanghai, Nio is one of several companies leading the charge in the EV revolution.

Motley Fool yesterday

NIO
Rumble Gets $775 Million Investment From Crypto Firm Tether

Video platform Rumble said it entered an agreement for an investment from the cryptocurrency company Tether.

The Wall Street Journal 2 days ago

RUM

RUMBW

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

EGB OE TS.Z./DUERR (AT0000A31U42.VI)

Related News

The comeback of REITs: Top ways to play commercial real estate

Singapore Post Shares Slide After CEO Fired Over Whistleblower Report

Donald Trump’s Agenda Has New Enforcers: Charlie Kirk and a Legion of Influencers

Singapore Post fires CEO over handling of whistleblower report

Why Is NIO Inc. (NIO) the Best Small Cap EV Stock to Invest In?

We're Interested To See How IonQ (NYSE:IONQ) Uses Its Cash Hoard To Grow

Is Merck the Next Big Weight-Loss Stock?

The Investing Cult Fueling MicroStrategy’s Ascent: ‘Have Fun Staying Poor’

China’s Nio Unveils $108,000 EV to Take on Porsche, Mercedes

Palantir Technologies (PLTR) Extends $400M Partnership with U.S. Army to Enhance Data and AI Capabilities

China's Nio introduces Firefly brand to take on BMW's Mini

Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy?

Novo obesity data positive for Eli Lilly and Amgen, says UBS

Jefferies sees Novo dropping ‘at least’ 10%-15% on obesity data

Weight loss seen with Novo’s CagriSema weaker than expected, says BofA

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

How to Build a High-Quality Passive Income-Producing Real Estate Portfolio for Less Than $250 at a Time

Is Now a Good Time to Buy the Dip in Eli Lilly Stock?

Nio: Buy, Sell, or Hold?

Rumble Gets $775 Million Investment From Crypto Firm Tether